PerAspera Holdings Ltd. announces the formation of Chemia Analytics Inc. for cannabis testing

August 25th, 2018 – PerAspera Holdings Ltd. (“PerAspera” or the “Company”) announces the formation of Chemia Analytics Inc. for cannabis testing. Managing Director Andy Hale stated, “With the formation of Chemia Analytics, PerAspera will have an independent cannabis testing business unit that can provide 3rd party services to Adastra Labs while servicing the growing cannabis industry in the British Columbia Lower Mainland.”

Chemia Analytics Inc. (“Chemia”) will leverage the scientific expertise of PerAspera’s two Quality Assurance Persons with substantial experience in the analytical laboratory setting in both research and the chemical industries.  Chemia Analytics will provide the full suite of testing services required to become a fully licensed analytical testing facility. These services will include Full Cannabinoid identification (14 total, including THC and CBD equivalents), Metals Analysis, Aflatoxin Analysis, Microbial Analyses (TAMC,TYMC, BTGN, E. coli, Salmonella), Foreign Matter, Loss of Drying, Oil Density, Terpene Profiling, and Pesticide Screening.

Chemia will be co-located in the PerAspera Township of Langley 13,035 square foot facility where approximately 1,000 square feet will be dedicated to analytical equipment and testing.  Chemia will us the Thermo Scientific line of analytic equipment including state-of-the-art High Performance Liquid Chromatography (HPLC) Triple Quadrupole Mass Spectrometry (MS), and Gas Chromatography(GC) MS, Inductively Coupled Plasma (ICP) MS analytic systems.

Further Information

For further information, please contact:

Andy Hale, Managing Director

Email: info@perasperaholdings.ca

About PerAspera Holdings Ltd.

In Canada, PerAspera (through its wholly-owned subsidiary, Adastra Labs Inc. and Chemia Analytics Inc.) is in the application process to become a Standard Processor under the Cannabis Act administered by Health Canada, with licences to produce cannabis extracts and provide third party analytical testing services. These licences will further enable PerAspera and its subsidiaries to produce, package, sell (wholesale), and export medically focused and recreational cannabis extract and concentrate products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis extraction products are legal.

The Company’s operations includes a facility in British Columbia, Canada. The Company is developing its 13,035 square feet facility to be fully devoted to standard processing and laboratory testing by early 2019, from which it expects to produce significant amounts of cannabis oil for the Canadian wholesale medical and recreational markets.

The Company will offer a suite of unique products under several existing consumer-focused brands, including tinctures, medicinal oils, concentrates, and when legalized, gel capsules and vaporizer pens. Through acquisition of existing cannabis extraction brands and careful development of its new brands, PerAspera will be positioned to be a leader in branded, commercialized products in both the medical and adult-use markets across North America and internationally.

Duis iaculis mattis rutrum. Sed iaculis magna sit amet suscipit ornare. Nulla ornare leo a tortor aliquam, quis interdum ex tempor. Quisque ultricies consequat suscipit. Donec tincidunt tempor ornare. Praesent a enim vel augue suscipit auctor in gravida augue. Suspendisse ut libero sit amet augue molestie fringilla. Fusce molestie, velit a finibus eleifend, nibh odio sagittis est, id aliquet turpis orci quis nibh. Donec tincidunt tempor ornare. Praesent a enim vel augue suscipit auctor in gravida augue. Suspendisse ut libero sit amet augue molestie fringilla. Fusce molestie, velit a finibus eleifend, nibh odio sagittis est, id aliquet turpis orci quis nibh. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Proin gravida nibh vel velit auctor aliquet. Aenean sollicitudin, lorem quis bibendum auctor, nisi elit consequat ipsum. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper.

Scroll to Top